Back
MEI Pharma Vs. Revance Therapeutics Industry Stock Comparison
Buy
61
MEIP
MEI Pharma
Last Price:
3.00
Seasonality Move:
4.15%
Sell
15
RVNC
Revance Therapeutics
Last Price:
4.32
Seasonality Move:
7.02%
Buy
61
MEI Pharma (MEIP)
is a Buy
Is MEI Pharma a Buy, Sell or Hold?
- The current MEI Pharma [MEIP] share price is $3.03. The Score for MEIP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- MEIP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
15
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $4.25. The Score for RVNC is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MEIP Stock Price Chart
What is MEI Pharma's stock price today?
-
The MEI Pharma share price today is $3.03
The current trend is moderately bullish and MEIP is experiencing selling pressure, which indicates risk of future bearish movement.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $4.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing buying pressure, which is a positive indicator for future bullish movement.
MEIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 54.6 | Buy |
| Chaikin Money Flow: | -13488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.73 - 3.09) | Buy |
| Bollinger Bands (100): | (2.79 - 3.29) | Sell |
RVNC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 37.32 | Sell |
| Chaikin Money Flow: | 1491457 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.55 - 5.91) | Sell |
| Bollinger Bands (100): | (3.54 - 6.32) | Sell |
MEIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.06 | Sell |
| 20-day SMA: | 2.96 | Buy |
| 50-day SMA: | 2.93 | Buy |
| 200-day SMA: | 3.32 | Sell |
| 8-day EMA: | 3.06 | Sell |
| 20-day EMA: | 2.99 | Buy |
| 50-day EMA: | 2.98 | Buy |
| 200-day EMA: | 3.63 | Sell |
RVNC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.84 | Sell |
| 20-day SMA: | 5.23 | Sell |
| 50-day SMA: | 5.53 | Sell |
| 200-day SMA: | 4.65 | Sell |
| 8-day EMA: | 4.61 | Sell |
| 20-day EMA: | 5.06 | Sell |
| 50-day EMA: | 5.24 | Sell |
| 200-day EMA: | 6.16 | Sell |
MEI Pharma Earnings Growth & MEIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.14 per share, and a decrease next year of $8.92 per share.
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.71 per share.
MEI Pharma Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Revance Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||